胆管がんの市場規模、シェア、成長分析：適応症別、治療別、エンドユーザー別、地域別、セグメント別予測、2025～2032年

胆管がんの世界市場規模は、2023年に36億米ドルと評価され、2024年の39億1,000万米ドルから2032年には75億米ドルに成長し、予測期間（2025～2032年）のCAGRは8.5％で成長する見通しです。

胆管がん市場は、罹患率の上昇、技術の進歩、研究開発の増加によって大きな成長を遂げています。米国では毎年約8,000人が胆管がんと診断されており、特に高齢化社会と肝フルク感染や肝炎の影響を受ける地域で有病率が上昇しています。PET-CTやMRIを含む画像診断の革新は、早期発見と治療計画を強化するもので、メモリアル・スローン・ケタリングがんセンターのような施設での先進技術の使用がその例です。さらに、アラン・モレメント記念基金のような啓発活動の高まりは、原因や治療に関する調査の重要性を浮き彫りにしています。しかし、限られた後期治療、高額な治療費、特に低所得国での早期診断の困難さなど、課題も残されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 価格分析
• ケーススタディ分析
• 技術分析
• 臨床試験分析
• FDA承認医薬品分析
• 規制分析

胆管がん市場規模：適応症別

• 市場概要
• 肝外胆管がん
  • 肝門部胆管がん
  • 遠位胆管がん
• 肝内胆管がん

胆管がん市場規模：治療別

• 市場概要
• 手術
  • 腹腔鏡検査
  • 胆道バイパス
  • ステント留置
  • その他
• 放射線治療
  • 外照射放射線療法（EBRT）
  • 内部放射線療法
• 化学療法
• 標的薬物療法
  • FGFR2阻害剤
  • IDH1阻害剤
  • TRK阻害剤
  • その他
• 免疫療法
• 緩和療法

胆管がん市場規模：エンドユーザー別

• 市場概要
• 病院とクリニック
• がん専門クリニック
• その他

胆管がん市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Memorial Sloan Kettering Cancer Center（MSK）
• The University of Texas MD Anderson Cancer Center
• City of Hope
• Mass General Brigham Incorporated
• Scripps Health
• Moffitt
• Cleveland Clinic
• Winship Cancer Institute of Emory University
• penn Medicine（Abramson Cancer Center）
• University Hospitals
• Kokilaben Dhirubhai Ambani Hospital
• Apollo Hospitals
• BLK-Max Super Speciality Hospital
• Max Healthcare
• Mayo Clinic
• Dana-Farber Cancer Institute
• Johns Hopkins Hospital
• Mount Sinai Hospital
• UCSF Health-UCSF Medical Center
• UCLA Medical Center

結論と提言

Global Bile Duct Cancer Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.91 billion in 2024 to USD 7.5 billion by 2032, growing at a CAGR of 8.5% during the forecast period (2025-2032).

The bile duct cancer market is experiencing substantial growth driven by rising incidence rates, technological advancements, and increased research and development. Each year, approximately 8,000 individuals in the U.S. are diagnosed with cholangiocarcinoma, with prevalence rising, particularly among aging populations and regions affected by liver fluke infections and hepatitis. Innovations in diagnostic imaging, including PET-CT and MRI, enhance early detection and treatment planning, exemplified by the use of advanced techniques at institutions like Memorial Sloan Kettering Cancer Center. Additionally, growing awareness initiatives, such as those by the Alan Morement Memorial Fund, highlight the importance of research into causes and treatments. However, challenges remain, including limited late-stage therapies, high treatment costs, and difficulties in early diagnosis, particularly in lower-income countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bile Duct Cancer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bile Duct Cancer Market Segments Analysis

Global Bile Duct Cancer Market is segmented by Indication, By Treatment, By End User and region. Based on By Indication, the market is segmented into Extrahepatic Bile Duct Cancer and Intrahepatic Bile Duct Cancer. Based on By Treatment, the market is segmented into Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Immunotherapy and Palliative Therapy. Based on By End User, the market is segmented into Hospital & Clinics, Cancer Specialty Clinic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bile Duct Cancer Market

The global bile duct cancer market is experiencing robust growth driven by the increasing incidence of bile duct cancer and the expanding elderly population. Older adults are particularly susceptible to cancer due to a compromised immune system and extended exposure to risk factors, including chronic liver disease and liver infections. As a result, the projected statistics indicate a significant rise in cancer cases and fatalities among senior demographics, with anticipated figures of approximately 20.7 million new cases and 12.7 million deaths by 2040. This escalating prevalence underscores the urgent need for advancements in treatment and care strategies within the market.

Restraints in the Global Bile Duct Cancer Market

The Global Bile Duct Cancer market faces significant restraints due to the severe side effects associated with various cancer treatments, hindering patient adherence and overall market growth. Standard treatment options, including chemotherapy, targeted drug therapy, and radiation therapy, commonly lead to adverse effects that drastically impact patients' quality of life. These side effects often include hair loss, fatigue, nausea, and neutropenia. Additionally, the apprehension regarding treatment-related toxicity affects patients' decisions regarding their treatment options and their readiness to participate in clinical trials, ultimately impeding the advancement of new therapeutic innovations in the market.

Market Trends of the Global Bile Duct Cancer Market

In the short term, the Global Bile Duct Cancer market is poised for significant growth, propelled by heightened awareness around early diagnosis and the demand for personalized treatment solutions. Innovations in diagnostic technologies, including molecular profiling and AI-assisted imaging, are set to improve treatment accuracy and efficiency. Moreover, the rising emphasis on precision medicine, coupled with the development of targeted therapies, is enhancing treatment options, enabling healthcare providers to offer bespoke therapeutic strategies that cater to individual patient profiles. As a result, these trends are collectively driving market expansion and fostering a positive outlook for the bile duct cancer sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Pricing Analysis
• Case Study Analysis
• Technology Analysis
• Clinical Trial Analysis
• Fda Approval Drug Analysis
• Regulatory Analysis

Global Bile Duct Cancer Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Extrahepatic Bile Duct Cancer
  • Hilar Bile Duct Cancer
  • Distal Bile Duct Cancer
• Intrahepatic Bile Duct Cancer

Global Bile Duct Cancer Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgery
  • Laparoscopy
  • Biliary bypass
  • Stent placement
  • Others
• Radiation Therapy
  • External beam radiation therapy (EBRT)
  • Internal radiation therapy
• Chemotherapy
• Targeted Drug Therapy
  • FGFR2 Inhibitors
  • IDH1 Inhibitor
  • TRK Inhibitors
  • Others
• Immunotherapy
• Palliative Therapy

Global Bile Duct Cancer Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital & Clinics
• Cancer Specialty Clinic
• Others

Global Bile Duct Cancer Market Size & CAGR (2025-2032)

• North America (By Indication, By Treatment, By End User)
  • US
  • Canada
• Europe (By Indication, By Treatment, By End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Indication, By Treatment, By End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Indication, By Treatment, By End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Indication, By Treatment, By End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Memorial Sloan Kettering Cancer Center (MSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The University of Texas MD Anderson Cancer Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• City of Hope
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mass General Brigham Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scripps Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moffitt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Winship Cancer Institute of Emory University
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• penn Medicine (Abramson Cancer Center)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• University Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kokilaben Dhirubhai Ambani Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Hospitals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BLK-Max Super Speciality Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Max Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayo Clinic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dana-Farber Cancer Institute
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johns Hopkins Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mount Sinai Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCSF Health-UCSF Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCLA Medical Center
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations